1st Optimal vs Midi Health: Which Costs Less, Takes Insurance, and Fits Your HRT Plan?

In the 1st Optimal vs Midi Health comparison, Midi Health is the lower-cost, lower-commitment starting point for most women with commercial PPO coverage and for anyone who wants FDA-approved menopause medications sent to a retail pharmacy. 1st Optimal fits the narrower buyer who wants monthly coaching, broad testing, and a compounded-forward functional-care model.

Midi Health is best for you if: you have a commercial PPO plan · you want general menopause care available in all 50 states · you prefer FDA-approved estradiol or progesterone products when clinically appropriate · you want a prescription routed through your pharmacy benefit · you do not want a required clinic membership.

1st Optimal is best for you if: you are paying cash or using HSA/FSA funds · you deliberately want monthly functional-health coaching, broad testing, ongoing messaging, and recurring clinical review · you are comfortable confirming the exact lab, medication, state, and contract terms in writing before paying.

Midi Health is not for you if: Medicaid or Medi-Cal is your coverage, because Midi says it cannot treat those patients even as self-pay · you need Medicare reimbursement, because Midi is out of network with Medicare and says beneficiaries cannot submit claims tied to its visits, medications, or associated services · you want one fixed all-in number covering every visit, lab, and drug.

1st Optimal is not for you if: you need the clinic to bill insurance · you want a public, treatment-specific medication price list before intake · you want one unambiguous cancellation rule on the website · you only want a straightforward menopause visit and retail-pharmacy prescription rather than a recurring functional-care program.

Who pays us, before you read a single number. Midi Health is not currently an approved affiliate partner, so if you book through our link, we do not earn a commission. 1st Optimal pays us nothing. We have no relationship with 1st Optimal, and our links to it earn us zero.

Neither company pays us for the recommendation on this page. That is still a setup you should examine carefully. Every commercial figure below comes from the provider’s own current pages, every conflict is shown rather than hidden, and every dated source is linked. Don’t take our word for any of it. Check us. Full affiliate disclosure →

1st Optimal vs Midi Health at a glance

Answer capsule. Midi charges for visits; 1st Optimal charges for an ongoing care program. The published headline fees are therefore not interchangeable: Midi lists $250 for an initial self-pay visit and $150 for follow-ups, while 1st Optimal lists $129 monthly for Perimenopause Care and $239 monthly for Menopause Care. The unresolved costs sit outside those numbers.

Decision fact	1st Optimal	Midi Health
What you are buying	A recurring functional-health membership with clinical oversight, coaching, messaging, lab review, and refill support	Individual menopause-focused virtual visits and a Care Plan
Published clinic fee	$129/month for Perimenopause Care; $239/month for Menopause Care	$250 initial self-pay visit; $150 self-pay follow-up
Required clinic membership	Yes	No required clinic membership
Insurance	Cash-pay model; HSA/FSA accepted	In-network with most PPO plans; HSA/FSA accepted; Medicare out of network; Medicaid and Medi-Cal not accepted
Labs	Public pages conflict: some say initial/follow-up labs or lab testing are included; another FAQ describes separate lab invoices	Ordered when clinically indicated; not included in the visit price; insurance coverage varies
Medication	Public BHRT pathway is compounded-forward; exact product and patient price must be confirmed during intake	Standard HRT page describes FDA-approved products; separate Midi Custom Rx and testosterone products are explicitly compounded
Where the prescription goes	Partner-pharmacy fulfillment is built into the public model	Standard prescriptions can be sent to the patient’s pharmacy; Midi Custom Rx products are purchased and shipped separately
State access	BHRT page says licensed providers in all 50 states; FAQ says to request the current state list	General menopause care in all 50 states; testosterone currently listed in 24 states plus D.C.
Minimum commitment	FAQ says month-to-month; Terms of Service state a 120-day minimum; other pages tie membership to the treatment protocol	No required clinic subscription for core visits
Best fit	Cash-pay patient who wants testing, coaching, and a high-touch recurring program	PPO patient or self-pay patient who wants visit-based menopause care and a retail-pharmacy pathway

Provider sources, all checked August 21, 2026: 1st Optimal Functional Health Plans · 1st Optimal FAQ · 1st Optimal Terms of Service · 1st Optimal BHRT Telehealth · Midi Pricing & Insurance · Midi appointment-cost FAQ · Midi HRT · Midi menopause care.

The right online HRT provider isn’t the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can’t resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn’t the right starting point — before your first consult.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

1. What are you actually buying from 1st Optimal or Midi Health?

Answer capsule. 1st Optimal sells an ongoing relationship with a care team: monthly consultations, coaching, messaging, lab review, and refill processing inside a recurring membership. Midi sells appointments. Its published clinic price buys the clinical visit and Care Plan; labs and medication remain separate. These are different products, not competing prices for the same unit.

Here is the mistake almost everyone makes with these two. They put $239 next to $250 and think the prices are close.

They are not even the same unit. One is a monthly retainer. The other is a one-time appointment charge. Comparing the two numbers without duration or inclusions is like comparing a gym membership with one personal-training session.

What 1st Optimal’s monthly fee is built to buy

On its Functional Health Plans page, 1st Optimal says every plan includes physician-guided care, functional-health coaching, refill processing, asynchronous care, monthly health consultations, in-depth lab reviews, portal access, ongoing messaging, priority booking, and free shipping and medical supplies.

That is a real product. Midi does not sell that bundle at any published price. If what you have been missing is someone who keeps reviewing the bigger picture rather than writing one prescription and disappearing, the recurring structure is not automatically a markup. It is the thing you are buying.

The problem is not that the bundle has no value. The problem is that 1st Optimal’s public pages do not agree on what is inside it. Its BHRT page says initial and follow-up labs are included. Its FAQ says the pricing model includes lab testing. The same FAQ also says invoices for labs, supplements, and prescriptions are processed separately. That contradiction matters because labs can be one of the largest non-medication costs.

What Midi’s visit fee is built to buy

Midi’s pricing page lists a 30-minute initial visit at $250 self-pay and a 15-minute return visit at $150 self-pay. With insurance, the allowed amount and your out-of-pocket share depend on the exact plan, deductible, copay, coinsurance, and state.

The visit fee does not include labs or prescriptions. That sounds less generous, but it creates a different kind of control: standard prescriptions can be routed through your pharmacy benefit, and there is no clinic membership to keep paying simply to remain a patient.

The shared-pharmacy finding — and the limit of what it proves

The pharmacy finding in the original comparison was real, but it needed one critical boundary added.

1st Optimal’s Terms of Service name Belmar Pharmacy — Colorado, a 503A pharmacy at 231 Violet Street, Suite 140, Golden, Colorado. Midi’s current progesterone product-safety page tells patients to follow package directions provided by Belmar Pharmacy and directs questions to Belmar Pharma Solutions.

So both companies publicly identify Belmar in connection with at least part of their compounded-medication pathways.

That does not prove that every compounded prescription from either company comes from Belmar. It does not prove that two patients receive the same formulation, dose, capsule base, testing history, shipping process, or price. It proves one narrower and useful fact: the provider brand is not the compounder, and the care model can differ even when a disclosed dispensing pharmacy overlaps.

A 503A pharmacy compounds a prescription for an identified individual patient. A 503B outsourcing facility may produce certain compounded drugs in batches for office use under a different federal framework. Neither label means the resulting drug is FDA-approved. FDA explains the distinction here.

Why this matters to you: do not buy the story that one logo automatically means “premium medicine” and another means “basic medicine.” Ask which exact product is being prescribed, whether it is FDA-approved or compounded, which pharmacy dispenses it, why that route fits you, and what it costs. The real decision is care model, formulation, commitment, and price — not brand mythology.

2. Which costs less in the 1st Optimal vs Midi Health comparison?

Answer capsule. Under a three-visit first-year scenario, Midi’s published self-pay clinic fees total $550. Twelve months of 1st Optimal membership total $1,548 or $2,868 before unresolved medication, testing, supplement, or treatment charges. The public pages do not support a universal all-in total because 1st Optimal’s lab-inclusion statements conflict and medication pricing is patient-specific.

The original draft’s $5,760–$10,155 1st Optimal total looked specific. It was not publishable.

It combined a 12-month membership, two retail lab panels, and a broad article-level estimate for “compounded bioidentical hormones” as though all three applied to the same actual patient. Meanwhile, 1st Optimal’s own current pages conflict on whether initial and follow-up labs are included. A precise-looking total built from incompatible assumptions is worse than no total at all.

Here is the comparison the public evidence can actually support.

Path	Published clinic-fee calculation	Published clinic-fee total for this scenario	What is still outside that number
1st Optimal Perimenopause Care — 12 months	$129 × 12	$1,548	Exact medication price; any labs not included; supplements, advanced diagnostics, and other prescribed treatments
1st Optimal Menopause Care — 12 months	$239 × 12	$2,868	Exact medication price; any labs not included; supplements, advanced diagnostics, and other prescribed treatments
Midi — three self-pay visits	$250 + $150 + $150	$550	Labs, prescriptions, and any additional visits
Midi — three insured visits using Midi’s published average	About $50 × 3	About $150	This is a provider-stated average, not a quote; deductible, copay, coinsurance, labs, prescriptions, and additional visits can change it

What we can verify about 1st Optimal’s lab prices

1st Optimal’s public shop lists women’s lab panels at $329.99, $549.99, and $857.99. Those are real public retail prices as of August 21, 2026. They are not proof that a member will be charged one of those amounts, because the BHRT page says initial and follow-up labs are included, the FAQ says lab testing is included in the pricing model, and another FAQ answer describes separate lab invoices.

That is why the final table does not add a lab panel to every 1st Optimal patient. The question is not “What does the shop sell?” The question is “Which exact panel is included in my $129 or $239 plan, and which tests can still be invoiced separately?”

What we can verify about medication prices

1st Optimal publishes no current women’s HRT price sheet that ties a specific formulation, quantity, and refill cadence to a patient’s membership. Its general HRT cost article discusses broad market ranges, but those are category estimates, not a treatment quote from 1st Optimal. We did not use them.

Midi separates standard retail-pharmacy prescriptions from its cash-pay Custom Rx line. Two current examples are public: its compounded oral progesterone page starts at $35 for a 30-day supply, and its compounded testosterone cream page starts at $100 for a 90-day supply. Those are product-specific listed prices, not promises that either drug is right for you or that your clinician will prescribe it.

For FDA-approved standard HRT through Midi, the actual drug cost belongs to your pharmacy benefit or cash pharmacy price. That number depends on product, dose, quantity, insurer, deductible, formulary, prior authorization, and pharmacy. It should not be guessed on this page.

The line to remember

Midi publishes a visit price. 1st Optimal publishes a membership price. Neither publishes your complete year-one bill before the clinical and coverage details are known.

For a typical visit-based comparison, Midi usually has the lower known clinic fees and no required monthly clinic membership. But the honest comparison is a labeled scenario, not a fake all-in total.

For a deeper breakdown of the unresolved 1st Optimal costs, see our 1st Optimal cost analysis. For Midi’s billing model, see the full Midi Health review.

Check Midi’s current self-pay price and your exact plan status

Midi’s checker can tell you whether your carrier and plan are listed before you book. The result is still not a guarantee of zero out-of-pocket cost, but it is the fastest way to replace a national average with your own starting number. Check Midi pricing and insurance → (editorial link — we do not earn a Midi commission)

3. What are you actually committing to?

Answer capsule. 1st Optimal’s public documents give three different answers. Its FAQ says month-to-month, its Terms require a minimum of 120 days, and women’s program pages say membership runs for the prescribed protocol, using 12 weeks as an example. Midi’s core clinic is visit-based and does not require a recurring membership. Get 1st Optimal’s controlling term in writing.

This is the most consequential finding on the page because it changes what $239 means.

The four public statements that do not line up

The following table is not our interpretation of one vague sentence. It is a conflict ledger built from four current pages.

1st Optimal source	What the page says	What it means before you pay
FAQ	Membership is billed month-to-month; no long-term contract; it auto-renews until a change request is made	The reader sees a one-month commitment
Terms of Service	Membership is for a minimum of 120 days; a change request may be submitted after the initial 120 days; seven days’ notice is required	The contract floor is at least 120 days
Women’s Hormones page	Membership duration runs for the prescribed treatment; a 12-week protocol is used as the example; it then auto-renews	Commitment may be linked to treatment duration
BHRT Telehealth page	Month-to-month; no long-term contract; pause or cancel anytime	The marketing page presents maximum flexibility

The innocent explanation comes first: websites drift. Teams update sales pages, FAQs, and Terms on different schedules. That happens constantly and is not proof of deception.

But you are the one signing. Treat the Terms as the controlling published contract—not the FAQ—unless 1st Optimal confirms a different term in writing before payment.

What 120 days can cost in membership charges

A 120-day minimum can cross four or five monthly draft dates, depending on the signup date, month lengths, which published billing calendar governs, and when a cancellation request can first take effect. These are labeled scenarios, not a claim that every account receives five drafts.

Plan	Four-charge scenario	Five-charge scenario
Perimenopause Care — $129/month	$516	$645
Menopause Care — $239/month	$956	$1,195

Why the fifth charge is possible under a literal reading: the Terms say the request comes after the initial 120 days and must arrive at least seven days before the next billing cycle. The FAQ, meanwhile, says drafts occur on the 1st or 16th. The Terms say billing repeats on the same day as the initial signup. Those are two billing calendars.

Billing dates and refill dates also conflict

The Terms say the membership bills monthly on the same day as signup. The FAQ and women’s program pages say drafts occur on the 1st or 16th, based on the signup half of the month.

The FAQ says invoices for labs, supplements, and prescriptions are processed about three weeks before an existing patient’s refill date. The women’s page says treatment orders are processed on the card on file six to seven weeks before the refill date, with advance notice. Prescribed treatments and telemedicine services are listed as nonrefundable in the Refund and Returns Policy.

That combination can matter more than the monthly price. A treatment charge processed weeks early may be difficult to reverse even when the next membership charge can be stopped.

The one message to send before entering a card

Ask this in writing:

“Which document governs my account today: the FAQ’s month-to-month answer, the 120-day minimum in your Terms, or the treatment-duration language on the women’s program page? What exact date will my membership draft, when can cancellation first take effect, and how far before a refill will any treatment charge be processed?”

Keep the reply. If the answer is month-to-month, you spent five minutes. If the Terms control, you just found out that four monthly Menopause Care charges total $956, not $239.

(No provider link in this section. Get the contract answer first.)

4. Will my insurance work with 1st Optimal or Midi Health?

Answer capsule. 1st Optimal is cash-pay and accepts eligible HSA/FSA funds; it does not submit insurance claims. Midi is in-network with most PPO plans, but each plan controls the deductible, copay, coinsurance, and coverage decision. Midi is out of network with Medicare and cannot treat Medicaid or Medi-Cal patients, including on a self-pay basis.

Four different things get jammed together under the word insurance. Separate them and the decision gets much easier.

1. Will the clinic bill your insurer?

• 1st Optimal: no. Its FAQ describes a cash-based model and says HSA/FSA cards are accepted.
• Midi: often, for commercial PPO plans. Its pricing page says it is in-network with most PPO plans nationwide, but coverage varies by plan and state.

2. Can you use HSA or FSA funds?

Both providers say yes for eligible expenses. That is a payment method, not insurance coverage. It does not guarantee that every membership, supplement, custom medication, or lab will qualify under your plan administrator’s substantiation rules.

Ask for an itemized receipt showing the date, service, provider, and amount. A card charge labeled only “membership” can trigger a documentation request.

3. Can you seek out-of-network reimbursement?

1st Optimal’s women’s testosterone guide says the company can provide superbills for potential reimbursement. That is not the same as billing insurance, and it is not a promise that your plan will pay.

Before relying on a superbill, ask which service it covers, whether the rendering clinician and group identifiers appear, which CPT and ICD-10 codes will be used, and whether the charge is for a covered medical service rather than a noncovered membership component.

4. Will insurance cover the drug?

That is separate from whether insurance covers the visit.

With Midi’s standard HRT pathway, the prescription can run through the patient’s pharmacy benefit. Coverage still depends on the exact FDA-approved product, generic or brand status, formulary, deductible, quantity limits, and prior authorization.

1st Optimal’s public BHRT pathway centers partner-pharmacy fulfillment. Belmar’s own patient information says it does not bill insurance and that many customized medications are not covered. That does not prove every 1st Optimal prescription is compounded or uninsured, but it is another reason to get the exact formulation and cash price before paying.

Where each insurance situation lands

The comparison below separates “can receive care” from “can use this insurance.” Those are not the same question.

Your situation	1st Optimal	Midi Health	Practical read
Commercial PPO	Cash-pay; potential superbill must be confirmed	In-network with most PPO plans; plan terms still apply	Midi usually wins on clinic cost after plan verification
HMO or out-of-network plan	Cash-pay	$250 initial / $150 follow-up self-pay if out of network	Compare actual cash totals and care model
Medicare	Cash-pay; no Medicare claim	Self-pay only; Midi says beneficiaries cannot submit related claims	Neither uses the Medicare benefit; compare known visit fees with 1st Optimal’s unresolved all-in cost
Medicaid or Medi-Cal	Cash-pay model, not an insurance solution	Cannot treat these patients even self-pay	Use an in-network or state-supported path instead
HSA/FSA funds	Accepted for eligible expenses	Accepted for eligible expenses	Either may work; keep itemized documentation

If you are on Medicare, read this before choosing

We are about to argue against our own paid recommendation. Do it anyway.

Midi’s biggest advantage is insurance billing. For a Medicare beneficiary, that advantage disappears. Midi says Medicare is out of network, visits are self-pay, and beneficiaries cannot submit claims connected with its visits, medications, or associated services.

That does not automatically make 1st Optimal cheaper. Midi’s self-pay visit fees are published; 1st Optimal’s medication and exact lab obligations are not. It makes this a cash-model comparison rather than an insurance comparison.

A separate HSA point: once enrolled in any part of Medicare, a person generally cannot keep contributing to an HSA, though existing HSA funds can still be used for qualified medical expenses. See IRS Publication 969.

If you have Medicaid or Medi-Cal, neither is the right insurance path

Midi states that it cannot treat Medicaid or Medi-Cal patients even as self-pay. 1st Optimal does not bill insurance, so it is not a way to use that benefit.

Start with a clinician or program that participates in your coverage. Your own OB-GYN, primary-care clinician, health system, or a state-licensed menopause service that accepts the plan is a completely legitimate answer. We earn nothing from that advice. We are telling you anyway.

For a deeper policy breakdown, see Does 1st Optimal take insurance? and our Midi Health review.

If you have a PPO, verify the exact plan before you pay

Carrier logos are not enough. Two plans from the same insurer can produce different networks, deductibles, and bills. Check whether Midi lists your state and plan → (editorial link — we do not earn a Midi commission)

5. Does each provider use FDA-approved or compounded HRT?

Answer capsule. Midi’s standard HRT page describes FDA-approved menopause medications, while its Custom Rx products and women’s testosterone cream are separately labeled compounded. 1st Optimal’s public BHRT pathway is compounded-forward and names a 503A pharmacy, but its complete women’s formulary is not publicly separated by FDA status. Ask for the exact product category before paying.

This is the part of the decision most women get talked out of understanding. So let’s be precise.

“Bioidentical” describes molecular structure. It does not tell you whether a product is FDA-approved or compounded. FDA-approved estradiol and micronized progesterone products can be bioidentical. A custom-compounded product may also be described that way. The word alone does not establish approval, quality, coverage, or superiority.

What Midi actually publishes

Midi’s standard HRT page says its clinicians prescribe FDA-approved bioidentical hormones and lists routes including pill, patch, vaginal ring, cream, and gel.

Midi also sells a separate Custom Rx line. Its store and product pages identify those medications as compounded and cash-pay. Its progesterone page, for example, labels the product compounded and lists a starting price of $35 for a 30-day supply. Its testosterone page lists a compounded cream starting at $100 for a 90-day supply.

That separation is the right way to present a mixed formulary: FDA-approved and compounded are not blended into one vague category.

What 1st Optimal actually publishes

1st Optimal’s BHRT page repeatedly describes compounded hormones through partner pharmacies and lists estradiol/estriol, oral progesterone, low-dose testosterone, DHEA, thyroid options, patches, creams, and pellets. Its Terms name Belmar’s Colorado 503A pharmacy.

The same page says medications are compounded at “FDA-registered pharmacies.” That phrase does not make the medication FDA-approved or the pharmacy FDA-approved or FDA-licensed. Registration is not approval.

What the public site does not provide is a current women’s table that says, product by product: FDA-approved commercial drug, off-label use of an approved drug, or compounded drug. That means the responsible conclusion is not “1st Optimal only prescribes compounded medication.” The responsible conclusion is: its public pathway is compounded-forward, and the exact category must be confirmed for your prescription.

What FDA and medical societies say

FDA states that compounded drugs are not FDA-approved and are not reviewed before marketing for safety, effectiveness, or quality. FDA also warns telehealth companies not to describe a compounded drug as a generic version of or the same as an FDA-approved drug, or to claim equivalent clinical results without adequate evidence. FDA does not approve or license pharmacies or facilities.

ACOG’s Clinical Consensus No. 6 says compounded bioidentical menopausal hormone therapy should not be prescribed routinely when FDA-approved formulations exist. The Menopause Society likewise explains that custom-compounded hormones have not been shown safer or more effective than approved bioidentical products.

Does that mean compounded medication is never appropriate?

No. Compounding can meet a real patient-specific need, such as an unavailable dose or an excipient problem that cannot be solved with an approved product. That is different from treating compounding as inherently more natural, safer, or more personalized.

The question to ask is simple:

“Is this prescription FDA-approved, an off-label use of an FDA-approved product, or compounded? If it is compounded, what patient-specific need makes compounding necessary in my case, and which pharmacy will dispense it?”

What about pellets?

1st Optimal lists pellets among its routes. ACOG recommends considering preparations other than pellet therapy because safety data are limited and a pellet cannot be easily removed or rapidly adjusted after implantation. If pellets are proposed, ask why a reversible FDA-approved route is not the better first option for your situation.

(No provider link in this section. Understand the formulation first.)

6. Do you really need all those hormone tests?

Answer capsule. 1st Optimal’s model makes broad testing central to the product; Midi’s menopause pathway says labs are targeted when needed to rule out another cause, guide treatment, or monitor health. Routine serum hormone testing is not generally required to diagnose typical perimenopause or titrate standard menopause therapy, but targeted tests can still change an individual decision.

This is the real philosophical split, and it is more useful than arguing about which website looks better.

1st Optimal’s argument: more data, then a broader plan

1st Optimal’s public women’s panels include combinations of estradiol, progesterone, total or free testosterone, SHBG, DHEA-S, LH, FSH, thyroid markers, CBC, metabolic markers, lipids, HbA1c, fasting insulin, iron studies, vitamin D, ApoB, Lp(a), hsCRP, and other markers depending on the panel. It also markets advanced diagnostics such as DUTCH and gut testing.

If you want a broad midlife workup with someone responsible for reviewing it over time, that is not commodity care. It is a real reason to choose the more intensive model.

Midi’s argument: symptoms first, targeted testing second

Midi’s menopause page says clinicians may recommend targeted labs to rule out other causes, guide treatment, or check bone, heart, thyroid, and metabolic health. Its appointment-cost FAQ is explicit that labs are not inside the visit price.

That does not mean “no testing.” It means the test follows a clinical question instead of being the product’s center of gravity.

What the guidance supports

ACOG’s compounded-hormone guidance says most patients do not need additional serum-hormone testing to titrate treatment for menopausal symptoms and that symptom response should guide dosing. Hormone values also fluctuate during perimenopause, so one blood draw can create a false sense of precision.

That does not make every broader panel useless. A clinician may reasonably investigate thyroid disease, anemia, metabolic risk, cardiovascular risk, or another diagnosis when the history points there. The value is not the number of markers. The value is whether a result changes what happens next.

Ask this question:

“Which result in this panel could change my diagnosis, medication, route, dose, or follow-up — and which results are informational only?”

A good clinician at either company should be able to answer. The answer tells you whether you are buying medicine, monitoring, risk assessment, curiosity, or a spreadsheet. There are honest reasons to want any of those. You should know which one you are paying for.

7. Which 1st Optimal plan will you be put in?

Answer capsule. 1st Optimal lists Perimenopause Care at $129 monthly and Menopause Care at $239 monthly, but it does not publish a clear assignment rule. The lower-priced card names testosterone therapy if applicable; the higher-priced card names estrogen, progesterone, and testosterone options. Confirm the plan and covered hormone categories before paying.

Read the two public plan cards side by side.

Published benefit	Perimenopause Care — $129/month	Menopause Care — $239/month
Hormones named on the card	“Personalized Testosterone Therapy if applicable”	“Estrogen, Progesterone & Testosterone Options”
Blood work	Ongoing blood-work monitoring and review	Ongoing blood-work monitoring and review
Coaching	Monthly perimenopause health coaching	Monthly functional coaching for menopause support
Guide	Women’s Hormone Optimization Guide	Healthy Aging & Menopause Guide

The step from one card to the other is $110 a month, $1,320 a year, or roughly an 85% increase over the $129 plan.

The published cards do not say who makes the assignment, whether stage alone controls it, whether estrogen or progesterone can ever be used under the lower tier, or whether the monthly fee changes after a clinician reclassifies the care pathway.

Do not assume that “Perimenopause Care” means every medication commonly discussed in perimenopause sits inside the $129 tier. The card does not say that. It names one hormone category and leaves the rest unresolved.

Ask before you pay:

“Which plan applies to me, who makes that decision, which hormone categories are available under that plan, and will my monthly membership change if my treatment or menopause stage changes?”

That one answer can move the annual membership total by $1,320. It belongs before checkout, not after the first lab review.

8. How long until you can actually start treatment?

Answer capsule. 1st Optimal publishes 5–7 business days for many lab results, up to 10–14 for some, followed by 7–14 business days for treatment processing and shipping by page. Midi says appointments may be available within days and many prescriptions are sent after the visit, but approvals and pharmacy timing can still add days or weeks.

Stack 1st Optimal’s own published steps and the process is not instant.

• Lab results: usually 5–7 business days, with some taking 10–14.
• Treatment processing after lab review: one current women’s page says 7–10 business days; the FAQ says 10–14 business days.
• Delivery: varies by location, treatment, and pharmacy workflow.

That creates a public-source range of roughly 12–28 business days from specimen collection through treatment processing or shipment, before adding the time needed to schedule, receive the kit, complete collection, hold the provider review, or handle a prescription question. It is a planning range assembled from the provider’s steps, not a guaranteed delivery date.

The membership can be billing during that interval. That is not proof of wrongdoing; testing, review, patient-specific compounding, and shipping take time. It is still a cost and timing fact you deserve before you are inside the process.

Midi’s path is shorter when no pre-prescription lab or authorization is needed: book the visit, meet the clinician, and have an appropriate standard prescription sent to the pharmacy. Midi says many prescriptions are sent immediately after a visit, often the same day, while some require approvals that take days or weeks. Retail pharmacy stock and insurer authorization remain outside Midi’s control.

The fair comparison is not “fast company versus slow company.” It is:

• 1st Optimal: testing-led sequence, provider review, then partner-pharmacy workflow.
• Midi: visit-led sequence, targeted testing when indicated, then retail-pharmacy or Custom Rx workflow.

If you have been awake at 3 a.m. for months, the difference between days and several business weeks is not abstract. Ask both providers for the steps that apply to your likely route before choosing.

If speed to a standard retail-pharmacy prescription is your priority

Midi’s visit-based pathway removes the required membership-and-broad-panel sequence. A clinician still decides what is appropriate, and no prescription is guaranteed. See current Midi appointment availability → (editorial link — we do not earn a Midi commission)

9. What do the independent reviews actually tell you?

Answer capsule. Review volume is useful only when the date, pool size, distribution, and platform method are visible. On August 21, 2026, 1st Optimal had seven Trustpilot reviews and a 3.7 TrustScore; Midi had 1,557 reviews and a 4.1 TrustScore. The first pool is too small for confidence; the second is meaningful but clearly mixed.

Trustpilot explains that its TrustScore calculation includes a prior weight equivalent to seven reviews at 3.5 stars so a business with little feedback does not swing instantly to an extreme score. That matters enormously here: 1st Optimal has only seven actual reviews.

Trustpilot snapshot — August 21, 2026	1st Optimal	Midi Health
Total reviews	7	1,557
Reviews in the last 12 months	5	819
TrustScore	3.7	4.1
Five-star share	86%	75%
Four-star share	0%	2%
Three-star share	0%	2%
Two-star share	0%	5%
One-star share	14%	16%
Negative-review response signal	Has not replied to negative reviews	Replied to 93% of negative reviews, typically within one week
Review-invitation signal	No recent history of asking for reviews	No recent history of asking for reviews

Source: Sources:* 1st Optimal on Trustpilot · Midi Health on Trustpilot · Trustpilot’s TrustScore explanation. Snapshot captured August 21, 2026; these figures will change.

Read the small pool fairly

1st Optimal’s 3.7 is not strong evidence for or against the company. With seven reviews, one new rating can move the distribution sharply, and the platform’s prior weight remains influential.

The real damaging admission is the absence of evidence: for a program that can carry four-figure annual membership fees before medications or disputed lab charges, seven independent reviews do not tell you much about billing consistency, clinician continuity, cancellation, or long-term support.

One 1st Optimal reviewer described the service experience this way:

“I can ask questions any time and always feel taken care of and a priority.”

That is a real, attributable Trustpilot review. It describes access and support, not a medical outcome, and it should be weighted as one person’s experience.

Read the large pool fairly

Midi has enough reviews to show both strength and friction. Three-quarters are five-star, but 16% are one-star and 5% are two-star. That is not a spotless profile. It is a large profile with a visible dissatisfied minority.

A recent independent reviewer wrote:

“I love that I never feel rushed during my appointments.”

Again, that is an individual report about the care experience, not proof that treatment will work for another patient.

What reviews cannot establish

Reviews can reveal repeated process complaints: billing, scheduling, communication, clinician fit, refill friction, or support response. They cannot establish that a hormone is safe for you, that a treatment caused an outcome, or that a result is typical.

We did not use either company’s dramatic before-and-after claims as evidence. We did not convert reviews into an invented provider score. A star rating without its pool size, distribution, platform method, and date is not a decision-grade fact.

10. Where does Midi Health fall down?

Answer capsule. Midi’s biggest weakness is not the published visit fee; it is the part the fee cannot settle. Insurance eligibility can still produce a deductible, copay, coinsurance, or coverage dispute, while labs and medication remain separate. Midi also excludes Medicaid and Medi-Cal patients and offers no Medicare reimbursement pathway. Its review and complaint footprint shows real service friction.

We are recommending Midi for most readers on this page. Midi does not currently pay us for this link. So here is the part that should make you examine the recommendation rather than trust it automatically.

The flaw: Midi cannot tell you your complete year-one cost

It can publish $250, $150, and an insured-patient average of about $50 per visit. It cannot turn those numbers into your final bill without your exact benefit design, deductible status, lab orders, medication, pharmacy, and follow-up cadence.

“In network” does not mean “covered at 100%.” Midi’s own help center says a new patient may owe up to the $250 deductible amount and a follow-up up to $150, plus any copay or coinsurance. Its pricing page says additional costs may apply.

This is the category where a clean eligibility result can still become a messy claim. Verify with Midi and the insurer. Save the eligibility response. Ask for the billing code and estimated patient responsibility. Do not treat a logo or automated match as a guarantee.

The complaint footprint is not imaginary

The Better Business Bureau listed Midi with a B rating, accreditation, 165 complaints over three years, and 114 complaints closed in the prior 12 months when checked on August 21, 2026.

Those numbers need context. BBB complaints are allegations and dispute records, not medical findings. The profile provides no patient-volume denominator, so it cannot tell you a complaint rate. Midi serves a large national population, and a raw count alone cannot establish that a typical patient will have a bad experience.

It can still tell you something useful: billing, access, communication, and continuity are not theoretical failure modes. Keep records and do not assume the platform will remember every promise made before the visit.

The advertising inquiry belongs on the record — proportionally

On February 25, 2026, the National Advertising Division closed an inquiry involving a Midi claim about how quickly patients found relief. Midi permanently discontinued the challenged claim during the inquiry, so NAD did not review it on the merits.

That was an advertising matter, not a safety finding. We do not repeat the retired percentage here. The practical lesson is narrower: do not choose a clinic because of a dramatic timeline claim. Choose based on clinical fit, access, formulary, cost, and follow-up.

Medicare and Medicaid are real holes in the model

Midi is built around insurance access, yet Medicare is out of network and Medicaid/Medi-Cal patients cannot be treated even as self-pay. For a national menopause clinic, those are not footnotes. They remove the central advantage for a large group of women.

Why Midi still wins for most readers here

Because the core clinic sells the visit, not a required membership. Standard prescriptions can go to a retail pharmacy and use the patient’s pharmacy benefit. There is no 120-day clinic floor, no monthly care fee to maintain, and no need to solve a cancellation conflict before booking.

That does not mean refills continue forever after you stop care. Prescriptions expire, clinicians control renewals, monitoring may be required, and controlled substances carry additional rules. It means the clinic’s standard model does not make a recurring membership the price of entry.

If one predictable cash program with coaching matters more than insurance, 1st Optimal may fit better. If Midi’s billing, access, or continuity risk is your dealbreaker, see our Midi Health alternatives. We earn nothing from 1st Optimal, and not every alternative on that page is an affiliate.

(No link to Midi in this section. This is the honest part.)

11. Where does 1st Optimal genuinely win?

Answer capsule. 1st Optimal bundles a type of ongoing support Midi does not sell as one package: monthly consultations, functional-health coaching, asynchronous messaging, lab review, refill processing, priority booking, and shipping or medical supplies. For a cash-pay patient who deliberately wants that relationship, the higher recurring fee can buy more than a prescription appointment.

Everything above was the cost and contract case against 1st Optimal. This is the case for it, and it is real.

Five things the membership is designed to provide

1. A monthly clinical conversation. If someone paid Midi’s current self-pay rates for one initial visit and eleven follow-ups, the visit fees alone would total $1,900. That is only an illustration — twelve visits may not be needed, and the services are not identical — but it shows why recurring access can have value.
2. Functional-health coaching. Nutrition, exercise, sleep, stress, and accountability are part of the public plan model. For a woman who already knows the prescription is only one part of the problem, that is a legitimate reason to pay more.
3. Ongoing messaging. The BHRT page describes unlimited messaging, while the broader plan page describes ongoing messaging and asynchronous care.
4. A team expected to review broad data over time. If your frustration is “nobody will put all these results together,” the 1st Optimal model is built to sell that synthesis.
5. Refill support, shipping, and medical supplies. The plan page lists refill processing and free shipping or medical supplies across plans, though medication itself is not shown as included in the monthly fee.

Who this genuinely fits

• You are paying cash anyway. No useful PPO benefit, an unreachable deductible, or a conscious choice to stay outside insurance.
• You have eligible HSA or FSA funds. Pre-tax dollars can change the effective cost, though the administrator may require substantiation.
• You want broad testing and coaching on purpose. Not because a sales page told you “more markers” always means better medicine, but because you value a comprehensive review and understand what the tests will change.
• You want a compounded pathway after an informed discussion. You know compounded is not FDA-approved, you understand why a commercial product does not meet your need, and the clinician can explain the pharmacy and formulation.
• You want a recurring relationship. The monthly structure feels like support, not a trap — after the term is confirmed.

What we would still get in writing first

1. Which document controls the minimum term and cancellation date.
2. Which lab panels are included in your exact plan and which can be billed separately.
3. What the prescribed medication will cost per fill and how early the card will be charged.
4. Whether the exact women’s service and medication are available in your state.
5. Which plan you will enter and whether estrogen and progesterone are available under it.
6. Whether the product is FDA-approved, an off-label use of an approved product, or compounded.
7. Whether a superbill applies to your service and what codes it will carry.

Those questions do not weaken the recommendation. They make the right-fit recommendation safe enough to act on.

If that high-touch bundle is what you actually want

Use 1st Optimal’s free consultation to get the seven answers above in writing before paying. We earn nothing if you choose it. Book 1st Optimal’s consultation → (no commission; no affiliate relationship)

12. What about testosterone for women?

Answer capsule. Both providers discuss testosterone for women, but access is not interchangeable with ordinary menopause HRT. No FDA-approved testosterone product is specifically indicated for women in the United States, testosterone is a Schedule III controlled substance, and a licensed prescriber must decide whether it is appropriate. Midi publishes a compounded product price and jurisdiction list; 1st Optimal does not.

Start with the fact that governs everything else: testosterone is not a supplement and it is not an over-the-counter add-on. The Drug Enforcement Administration lists testosterone in Schedule III. A prescription is required, and federal and state controlled-substance rules, clinician authority, pharmacy rules, monitoring, and follow-up can affect access.

FDA-approved testosterone products in the United States are approved for specified use in men, not with a female indication. A woman may receive an off-label use of an approved male product or a compounded preparation after a clinician’s evaluation. Those categories should never be blurred.

What Midi publishes

Midi lists a compounded testosterone cream starting at $100 for a 90-day supply and currently names these jurisdictions:

Arizona, California, Colorado, Delaware, Florida, Iowa, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Nevada, New Jersey, New Mexico, New York, North Carolina, Ohio, Oregon, Pennsylvania, Texas, Utah, Virginia, Washington, and the District of Columbia.

That is 24 states plus D.C. Midi’s page also says baseline and follow-up labs may be ordered and that coverage for those labs should be checked with the insurer.

The price is a product listing, not the total pathway cost. Visits, labs, and future follow-ups remain separate.

What 1st Optimal publishes

Both women’s plan cards mention testosterone. The $129 Perimenopause Care card says “Personalized Testosterone Therapy if applicable,” and the $239 Menopause Care card includes testosterone among estrogen and progesterone options.

1st Optimal does not publish a current treatment-specific women’s testosterone state list or patient-specific medication price. Its BHRT page says licensed providers operate in all 50 states, while the FAQ says to request the current state roster. For a controlled substance, the specific patient state, prescriber authority, and dispensing pharmacy matter more than a broad nationwide claim.

The five questions that prevent a second appointment or a dead end

1. Can the clinician assigned to me prescribe Schedule III medication in my state?
2. Is the proposed testosterone an off-label FDA-approved product or a compounded preparation?
3. Which symptom and diagnosis are we treating, and what evidence supports it?
4. Which baseline and follow-up monitoring will be required, and what will it cost?
5. How often must I return for a prescription or refill under the rules that apply to me?

Only one of these providers publishes a jurisdiction list and a current product price. That gives Midi a transparency advantage for testosterone. It does not guarantee eligibility or a prescription.

13. When is neither provider the right starting point?

Answer capsule. Online menopause care can be a reasonable first door, but it cannot perform a physical examination, imaging, biopsy, or urgent evaluation. Postmenopausal bleeding, a new breast or pelvic finding, severe unexplained pain, or a complex cancer, clot, stroke, heart, or liver history may require prompt in-person testing or coordinated specialist care before systemic hormone treatment.

Neither company can examine you through the screen. That is the honest limit of the category.

Get prompt medical evaluation for bleeding after menopause

Any bleeding after menopause needs evaluation. A telehealth clinician may help triage the first step, but the workup can require a pelvic examination, ultrasound, endometrial sampling, or another in-person test. Do not let a product page reassure you past the need to investigate the cause.

Coordinate care rather than accepting blanket rules for cancer history

A personal history of breast, uterine, ovarian, or another hormone-sensitive cancer does not belong in a generic eligibility funnel. Hormone therapy may be inappropriate in some situations, while some local treatments can still be considered in selected cases after nonhormonal options and specialist discussion.

The correct next step is individualized coordination with the oncology or gynecology team — not a blanket internet yes or no.

A clot, stroke, heart attack, or liver history changes the risk discussion

These histories can materially change whether systemic hormone therapy is appropriate and which route is considered. They are not details to bury in an intake form. Bring the diagnosis, dates, current medications, and relevant specialist records to the clinician making the decision.

Symptoms that need someone to look or test

Start in person or expect an in-person handoff for:

• unexplained pelvic pain, a pelvic mass, or persistent abdominal swelling;
• a new breast lump or concerning breast change;
• vulvar or vaginal symptoms that persist despite initial treatment, because dermatitis, infection, lichen sclerosus, vestibulodynia, and other conditions can overlap;
• neurologic, chest, breathing, or severe acute symptoms that may be urgent;
• any situation where the clinician says a physical examination, imaging, or tissue sample is needed.

Call emergency services for emergency symptoms. A telehealth comparison page is not the place to troubleshoot them.

Menopausal hormone therapy is not contraception

If pregnancy is still possible, ask about contraception separately. A menopause HRT regimen is not birth control, and “my cycles are irregular” is not the same as “pregnancy cannot happen.”

None of this is a reason to avoid online care. It is a reason to choose the correct door on the first try.

If you are not sure which category you are in, Find My HRT Path is built to flag when online care is not the right starting point — not merely to route everyone toward a provider.

(No provider link in this section.)

14. How did The HRT Index verify this comparison?

Answer capsule. We checked the current provider pages, contract language, help-center policies, product listings, pharmacy disclosures, review profiles, and regulatory sources on August 21, 2026. The original asset is not a score. It is a conflict-and-cost ledger showing what each provider states, what can be independently reproduced, and what still requires a written answer before payment.

What we actually checked

For 1st Optimal, we read the current Functional Health Plans page, FAQ, Terms of Service, Refund and Returns Policy, BHRT Telehealth page, women’s hormone program page, lab-panel shop listings, women’s testosterone material, HRT cost article, and the company’s provider-comparison article. We also checked the pharmacy named in its Terms.

For Midi, we read the current Pricing & Insurance page, appointment-cost and billing help articles, prescription and Care Plan help articles, HRT and menopause pages, Custom Rx store and product pages, product safety information, testosterone availability list, Trustpilot profile, BBB profile, and the NAD case summary.

We then checked FDA compounding guidance, DEA scheduling, ACOG’s compounded-hormone consensus, The Menopause Society’s hormone-therapy guidance, IRS HSA rules, and the Trustpilot scoring method.

What we did not do

We did not complete either intake to the payment screen, become a patient, receive a prescription, obtain a patient-specific 1st Optimal medication quote, test cancellation with an active account, or independently audit every clinician’s license. We also did not assume that a broad “all 50 states” marketing statement proves that every product, controlled substance, or clinician is available in every state.

That boundary matters. A page can verify what a company publishes. It cannot turn a public statement into your eligibility, your prescription, or your bill.

Provider-stated versus verified: the decision ledger

This table is the page’s proprietary evidence block. It combines pricing, inclusions, contract terms, pharmacy route, medication category, insurance, and jurisdiction claims from more than five primary sources, then separates reproducible facts from unresolved intake questions.

Decision point	Provider-stated fact	What we verified on August 21, 2026	What you still need to confirm
1st Optimal monthly price	$129 Perimenopause Care; $239 Menopause Care	Both figures appear on the current Functional Health Plans page	Which plan you will enter and whether the fee changes with treatment stage
1st Optimal labs	BHRT page says initial/follow-up labs included; FAQ says lab testing included; another FAQ answer describes separate lab invoices	The public pages conflict; shop panels list $329.99, $549.99, and $857.99	Exact included panel, cadence, draw fee, and every test that can be invoiced separately
1st Optimal commitment	FAQ and BHRT page say month-to-month; Terms say 120-day minimum; women’s page links duration to protocol	All three statements are live at the same time	Which document governs your account and first effective cancellation date
1st Optimal billing day	FAQ/women’s page say the 1st or 16th; Terms say signup-date billing	Both calendars are live	Exact first and recurring draft dates for your signup date
1st Optimal state access	BHRT page says providers in all 50 states; FAQ tells readers to request the current state list	Both statements are live	Your exact women’s service, medication, prescriber, and pharmacy availability
1st Optimal medication	BHRT pages describe made-to-order or partner-pharmacy treatment; Terms name Belmar’s Colorado 503A pharmacy	Compounded fulfillment is clearly part of the model; no patient-specific women’s HRT price sheet is public	Product name, FDA-approved/off-label/compounded category, quantity, refill cadence, and cash price
Midi clinic price	$250 first self-pay visit; $150 return visit	Both figures appear on pricing and billing pages; labs and prescriptions are excluded	Expected follow-up count and any separate specialist or service charge
Midi insured cost	Most insured patients average about $50 out of pocket per visit	The number is Midi’s national average, not a plan quote; deductible up to the cash visit amount may apply	Carrier eligibility, network status, allowed amount, deductible, copay, and coinsurance
Midi medication route	Standard prescriptions can go to a preferred pharmacy; Custom Rx products are bought and shipped separately	Both pathways are documented in Midi’s help center and Terms	Which pathway your clinician recommends and the pharmacy benefit or product price
Midi medication category	Standard HRT page describes FDA-approved hormones; Custom Rx pages identify compounded products	The categories are publicly separated	Exact product, dose, indication, coverage, and whether compounding is clinically necessary
Midi general access	General menopause care in all 50 states	Current menopause page says all 50 states	Clinician availability, insurer participation, and appointment time in your state
Midi testosterone access	$100 starting price for a 90-day compounded cream in 24 states plus D.C.	Product page lists the price and jurisdictions	Eligibility, prescriber authority, labs, follow-up schedule, and final dose-dependent cost
Shared pharmacy finding	1st Optimal’s Terms name Belmar; Midi’s compounded progesterone safety page names Belmar	Belmar appears in both document trails	Whether your specific prescription from either provider will use Belmar

The HRT Index Verification Standard

We apply The HRT Index Verification Standard across five pillars, always in this order: clinical legitimacy, care quality, medication fit, price transparency, access. It is a documented review process, not a numeric score and not a substitute for clinical judgment.

Pillar	1st Optimal	Midi Health
Clinical legitimacy	Public medical-care model, named Terms, named partner pharmacy, and licensed-provider claims; broad marketing language still needs product-level verification	National telehealth medical model with public clinician and health-system information; prescriptions remain clinician-dependent
Care quality	High-touch recurring model with monthly consultations, coaching, messaging, and broad lab review; independent review pool is extremely small	Menopause-focused visits with Care Plans and follow-up; large review pool shows both strong satisfaction and material billing or continuity complaints
Medication fit	Compounded-forward BHRT pathway with pellets among published routes; exact product category must be confirmed	FDA-approved standard HRT pathway plus separately labeled compounded Custom Rx and testosterone options
Price transparency	Membership prices are public, but lab inclusions, contract term, billing day, and medication price do not resolve cleanly	Visit fees and major insurance exclusions are public; labs, medication, benefits, and follow-up cadence prevent a universal all-in total
Access	Cash/HSA/FSA model; an all-50-states claim conflicts with a FAQ that directs readers to request the current roster	General menopause care in all 50 states; most PPOs; Medicare out of network; Medicaid/Medi-Cal unavailable; testosterone jurisdiction-limited

The closest provider-owned comparison does not settle the question

1st Optimal publishes a page titled “6 Cheapest Online Hormone Replacement Therapy Options” that places 1st Optimal first and Midi second. It is a provider-owned ranking, not an independent comparison, and it does not publish a comparable all-in price for all six providers.

There is nothing inherently wrong with a company comparing itself with competitors. The relationship is visible in the domain. The problem comes when a “cheapest” list does not show the complete, like-for-like price inputs a reader would need to reproduce the ranking.

That gap is why this page uses published-fee scenarios, a conflict ledger, and an open-question column instead of pretending the providers publish one clean year-one number.

What would force us to update this page

We re-check this comparison monthly. The page changes when any of these move:

• 1st Optimal membership prices, plan benefits, lab inclusions, medication pricing, cancellation language, billing date, state coverage, pharmacy, or refund rules;
• Midi visit fees, insurer participation, Medicare/Medicaid policy, general or testosterone availability, Custom Rx pricing, pharmacy route, or billing policy;
• FDA approval or safety status, federal testosterone scheduling, telehealth prescribing rules, or major society guidance;
• Trustpilot counts, distributions, and response signals, or the BBB complaint summary;
• the commercial relationship or destination of /go/midi/.

A changed timestamp without a re-check is not verification. The date at the top moves only when the commercial and regulatory fields above are checked again.

15. What should you ask before paying either provider?

Answer capsule. The highest-value move is not another hour of reading. It is getting the unresolved terms in writing. For 1st Optimal, the essential questions are commitment, lab inclusion, medication price, state access, and plan assignment. For Midi, they are exact network status, patient responsibility, clinician authority, lab cost, and the prescription pathway your Care Plan will use.

Print this. Paste it into support chat. Use it with either company and keep the response.

Ask 1st Optimal

1. Which membership rule governs me today: month-to-month, the 120-day minimum, or the length of my prescribed protocol?
2. What is my first possible cancellation date, what notice is required, and what exact day will my card draft?
3. Which initial and follow-up lab panels are included in my $129 or $239 membership, by name and marker list?
4. Which labs can still be billed separately, and what are their current patient prices?
5. What will my medication cost per fill, what quantity does that buy, and how many days before the refill will my card be charged?
6. Which plan will I be assigned to, who decides, and does the $129 plan include estrogen or progesterone when clinically appropriate?
7. Is my exact service and medication available in my state, including any controlled-substance prescription?
8. Will the proposed product be FDA-approved, an off-label use of an approved product, or compounded? If compounded, why does an FDA-approved option not meet my clinical need?
9. Can you issue a superbill for my service, and which rendering provider, NPI, CPT, and ICD-10 information will appear?

Ask Midi

1. Is my exact plan in network for the clinician and medical group I will see, not merely the carrier name on my card?
2. What is my estimated patient responsibility after deductible, copay, and coinsurance, and what happens if the carrier later rejects the claim?
3. Can the clinician assigned to me prescribe the medication category I am seeking in my state, including Schedule III testosterone when relevant?
4. Which labs are likely before or after treatment, where will they be performed, and how will insurance or cash billing work?
5. Will the prescription go to my pharmacy or Midi Custom Rx, and what will the medication cost before I authorize the order?

Do these two things regardless of provider

First, ask for an itemized receipt that identifies the date, service, clinician or medical group, and amount. HSA/FSA administrators and out-of-network plans may require more than a line that says “membership.”

Second, save every eligibility result, written pricing answer, contract term, lab inclusion, and medication quote before paying. A screenshot is not paranoia. It is your record of the decision you were asked to make.

Turn the written answers into a fit decision

Take those answers into Find My HRT Path →. The tool matches on insurance, state, medication route, risk history, and care-model preference—and flags when online care is not the right starting point.

16. So which should you choose: 1st Optimal or Midi Health?

Answer capsule. Choose Midi Health when you want visit-based menopause care, commercial PPO access, and an FDA-approved retail-pharmacy pathway without a required membership. Choose 1st Optimal when you knowingly want a cash-pay, testing-heavy, coaching-led relationship and will resolve the contract, lab, medication, and state questions first. Neither is the automatic answer for every woman.

Find yourself in this table.

If this is your situation	Start here	Why
Commercial PPO and you want the lowest known clinic fees	Midi Health	The clinic bills eligible PPO plans, publishes $250/$150 self-pay visit fees, and requires no monthly clinic membership
You specifically want FDA-approved menopause medication when appropriate	Midi Health	Its standard HRT pathway identifies FDA-approved products and can route prescriptions to a retail pharmacy
You want testosterone for women	Midi Health first, if your jurisdiction is listed	Midi publishes 24 states plus D.C. and a compounded product price; eligibility, labs, and a Schedule III prescription are still required
You want broad testing, monthly coaching, and recurring review on purpose	1st Optimal	That is the bundle it is built to sell; get the term, lab inclusions, medication quote, and state access in writing first
You are paying cash and hate insurance uncertainty	Compare the actual written totals	1st Optimal offers a cash-only relationship; Midi offers fixed self-pay visit fees but leaves labs and medication separate
You have Medicare	Compare Midi self-pay with 1st Optimal and your own clinician	Midi accepts Medicare beneficiaries only as self-pay and bars claim submission; 1st Optimal is cash-pay, not Medicare-covered care
You have Medicaid or Medi-Cal	Use an in-network or public-benefit pathway, not Midi	Midi cannot treat you even as self-pay; 1st Optimal’s cash model does not use your benefit
You already have a clinician and mainly need an inexpensive retail prescription	Neither may be necessary	A separate recurring program can add cost without solving a care gap you already filled
You have postmenopausal bleeding, a new mass, severe unexplained pain, or another examination-dependent concern	In-person evaluation first	A virtual visit cannot provide the physical examination, imaging, biopsy, or urgent assessment the situation may require

The final verdict

For most women comparing these two because they want menopause treatment without turning it into a second job, Midi Health is the cleaner first door. It has the lower published clinic-fee path in a typical visit-based year, broad PPO participation, nationwide general menopause access, and a standard pathway that can put an FDA-approved prescription at the pharmacy you choose.

That recommendation is not universal. Midi can still produce an insurance bill, it cannot serve Medicaid or Medi-Cal patients, Medicare offers no reimbursement path, labs and medication are extra, and a large review pool contains real billing and continuity complaints.

1st Optimal wins when the thing you want is exactly what makes it expensive: a recurring, testing-heavy, coached relationship. The bundle is real. So are the public contradictions around its lab inclusions, minimum term, billing day, and state access. The right buyer does not ignore those. She gets them answered, prices the medication, and chooses with her eyes open.

You want to sleep. You want your brain back. You want to stop being told this is normal while nobody gives you a usable plan.

You are not being talked into anything. You have probably been thinking about this longer than you admit to anyone. The choice is not “real care” versus “fake care.” It is a visit-based menopause clinic versus a recurring functional-care program — and the correct door depends on what you actually want to buy.

The worst outcome is not choosing the more expensive model. It is paying before the unanswered terms are answered — or spending another year circling the same decision because every page gave you slogans instead of numbers.

The smallest next step for the most common fit

If you have commercial PPO coverage and want visit-based menopause care, check your exact plan and current self-pay fallback before booking. Check Midi coverage and current pricing → (editorial link — we do not earn a Midi commission)

Still deciding? Use Find My HRT Path → for a personalized starting-point plan, including the flag for when online care is not the right first door.

17. Frequently asked questions

Is 1st Optimal legit?

1st Optimal is an operating cash-pay telehealth company with public plan prices, Terms, clinical-care pages, and a named partner pharmacy. That does not resolve the parts that matter before payment: its pages conflict on labs, membership length, billing date, and state availability, and it does not publish a patient-specific women’s HRT medication price. Get those in writing.

Does 1st Optimal take insurance?

No. Its FAQ describes a cash-based model and says eligible HSA/FSA funds are accepted. A women’s testosterone article says superbills may be available for potential out-of-network reimbursement, but the patient files the claim and payment is not guaranteed. Confirm that a superbill applies to your exact service before relying on it.

How much does 1st Optimal cost?

The published clinic membership is $129 per month for Perimenopause Care and $239 per month for Menopause Care. Four monthly charges equal $516 or $956; five equal $645 or $1,195. Labs and medication cannot be added reliably from the public pages because lab-inclusion statements conflict and no patient-specific women’s medication price sheet is published.

How much is Midi Health without insurance?

Midi publishes $250 for an initial self-pay visit and $150 for a return visit. The visit price excludes labs and prescription medication. A three-visit first year would therefore carry $550 in clinic visit fees before those separate costs, but your clinician—not this page—determines how many follow-ups are needed.

Which one costs less?

Midi usually costs less in clinic fees for the common visit-based scenarios shown here. Three self-pay visits total $550, and Midi says insured patients average about $50 out of pocket per visit, though individual benefits can reach the full cash rate. Twelve months of 1st Optimal membership total $1,548 or $2,868 before unresolved medication and possible lab costs.

Are labs included with 1st Optimal?

The website does not give one reliable answer. Its BHRT page says initial and follow-up labs are included, its FAQ says lab testing is included in the pricing model, and another FAQ answer describes separate lab invoices. Ask for the included panel name, marker list, cadence, and every separately billable test in writing.

Does Midi include labs in the visit price?

No. Midi’s billing and appointment-cost pages state that labs and prescription medication are not included in the visit price. Labs are ordered when clinically indicated, and insurance coverage or cash cost depends on the test, laboratory, and benefit plan.

Does 1st Optimal prescribe FDA-approved hormones?

Its public BHRT pathway is compounded-forward and its Terms name a 503A compounding pharmacy, but the site does not publish a complete patient formulary proving that every possible prescription is compounded or that no approved product is ever used. Ask for the exact product category. Compounded drugs are not FDA-approved.

Does Midi prescribe compounded hormones?

Yes, in a separate pathway. Midi’s standard HRT page describes FDA-approved hormone options, while Midi Custom Rx pages explicitly sell compounded products, including compounded progesterone and testosterone. A provider offering both categories does not make them equivalent. Your Care Plan should identify which one is proposed and why.

How do I cancel 1st Optimal?

The Terms say cancellation or pausing uses the Membership Change Request and that memberships must remain active for at least 120 days, with seven days’ notice before the next billing cycle. The FAQ and BHRT page say month-to-month or cancel anytime. Confirm the controlling rule and first effective cancellation date before signup.

Does Midi Health take Medicare?

No. Midi says Medicare and Medicare-related plans are out of network. Medicare beneficiaries may book as self-pay, but Midi says they cannot submit claims related to Midi visits, medications, or associated services.

Does Midi Health take Medicaid or Medi-Cal?

No. Midi says it cannot treat Medicaid or Medi-Cal patients at this time, even as self-pay patients. Use an in-network clinician, health system, community health center, or other benefit-compatible pathway instead of paying around the coverage you already have.

Can I use an HSA or FSA with either provider?

Both say eligible HSA/FSA funds can be used. Eligibility depends on the expense and plan rules, not merely the card being accepted. Ask for an itemized receipt. Once enrolled in any part of Medicare, a person generally cannot make new HSA contributions, but existing HSA funds can still pay qualified medical expenses.

Does either provider prescribe testosterone for women?

Both discuss it. Midi lists a compounded testosterone cream starting at $100 for a 90-day supply in 24 states plus D.C. 1st Optimal names testosterone in both women’s plans but does not publish a current treatment-specific state list or patient price. Testosterone is Schedule III and requires a prescription from an authorized clinician.

Is testosterone FDA-approved for women in the United States?

No testosterone product currently carries an FDA-approved female indication in the United States. A clinician may consider an off-label use of a product approved for men or a compounded preparation, but those are different regulatory categories. The prescription, dose, monitoring, and reason for treatment require individualized clinical judgment.

Are 1st Optimal and Midi using the same pharmacy?

The public documents connect both companies with Belmar in specific compounded pathways: 1st Optimal’s Terms name Belmar Pharmacy in Colorado, and Midi’s compounded progesterone safety information directs patients to Belmar materials. That does not prove every prescription from either company comes from Belmar. Confirm the dispensing pharmacy for your product.

What states do they serve?

Midi states that general menopause care is available in all 50 states; its testosterone page currently lists 24 states plus D.C. 1st Optimal’s BHRT page says licensed providers operate in all 50 states, while its FAQ tells patients to request the current state list. Confirm the exact service and medication before paying.

Can I switch from one provider to the other later?

Yes, but protect continuity first. Obtain your current medication name, strength, route, dose, refill date, pharmacy, latest lab results, and Care Plan. Confirm the receiving clinician can continue or reassess the treatment. If 1st Optimal’s 120-day minimum applies, calculate the notice and billing dates before canceling.

---

Still not sure which HRT program is right for you? Take our free 60-second matching quiz. Find My HRT Path →

---

Sources

1st Optimal commercial sources — checked August 21, 2026: Functional Health Plans · FAQ · Terms of Service · BHRT Telehealth · Women’s Hormones · Refund and Returns · HRT cost article · Provider-owned “6 Cheapest” comparison · Women’s testosterone guide · women’s lab-panel shop.

Midi commercial sources — checked August 21, 2026: Pricing & Insurance · appointment cost · billing · HRT · menopause care · prescription fulfillment · prescription timing · Custom Rx ordering · Custom Rx store · testosterone · compounded progesterone safety information · Terms and Conditions.

Medical and regulatory sources: FDA — Compounding and the FDA: Questions and Answers · FDA — What telehealth companies should know when promoting compounded drugs · ACOG Clinical Consensus No. 6 — Compounded Bioidentical Menopausal Hormone Therapy · The Menopause Society — 2022 Hormone Therapy Position Statement · ACOG — Postmenopausal bleeding evaluation · ISSWSH clinical practice guideline on systemic testosterone for women · ASRM/ReproductiveFacts — perimenopause and contraception · DEA drug scheduling · IRS Publication 969.

Review and accountability sources — snapshot checked August 21, 2026: 1st Optimal on Trustpilot · Midi Health on Trustpilot · Trustpilot TrustScore method · Midi BBB profile · Midi BBB complaint summary · NAD case closure, February 25, 2026.

Educational only — not medical advice. Talk to a licensed clinician about your own situation. FDA-approved and compounded medications are labeled distinctly throughout this page. Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before they reach patients. Prices, availability, insurance participation, and policies change; this page is re-verified monthly and the date at the top is updated only after re-checking.